First American dosed with Oxford-AstraZeneca phase three COVID-19 vaccine speaks out

Oxford University, in partnership with AstraZeneca, started testing the first U.S. volunteers as part of its phase three COVID-19 vaccine trial. CBS News chief medical correspondent Dr. Jon LaPook joins “CBS This Morning” with an exclusive interview with an American in the Oxford-AstraZeneca vaccine trial.

Read More

READ MORE:   IRS stimulus check: What to know about your eligibility, coronavirus payment, debit card

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button